KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to 0.07%.

  • Emergent BioSolutions' Return on Invested Capital rose 2100.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year increase of 2100.0%. This contributed to the annual value of 0.11% for FY2024, which is 2400.0% up from last year.
  • Per Emergent BioSolutions' latest filing, its Return on Invested Capital stood at 0.07% for Q3 2025, which was up 2100.0% from 0.06% recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Return on Invested Capital ranged from a high of 0.17% in Q1 2021 and a low of 0.49% during Q4 2023
  • Over the past 5 years, Emergent BioSolutions' median Return on Invested Capital value was 0.06% (recorded in 2022), while the average stood at 0.09%.
  • Per our database at Business Quant, Emergent BioSolutions' Return on Invested Capital crashed by -4700bps in 2023 and then skyrocketed by 3900bps in 2025.
  • Over the past 5 years, Emergent BioSolutions' Return on Invested Capital (Quarter) stood at 0.1% in 2021, then plummeted by -163bps to 0.06% in 2022, then plummeted by -668bps to 0.49% in 2023, then surged by 75bps to 0.12% in 2024, then skyrocketed by 156bps to 0.07% in 2025.
  • Its Return on Invested Capital stands at 0.07% for Q3 2025, versus 0.06% for Q2 2025 and 0.17% for Q1 2025.